The Biosimilars Forum was incorporated in Washington, DC, as a nonprofit organization to advance biosimilars in the United States with the intent of expanding access and availability of biological medicines, and improving health care. The Biosimilars Forum will provide evidence-based information to inform and support public policies that encourage awareness, access, and adoption of biosimilars.

The introduction of biosimilars in the United States may help expand access to high-quality treatment options for clinicians and patients as well as potentially reduce costs to families, caregivers, payers, and the entire health care system. Using state-of-the-art technology, biosimilars are manufactured using the same with the same high-quality systems and processes as existing biological medicines.

The FDA approval of the first biosimilar in the United States and the ongoing development and production of other biosimilars serve as important milestones. The founding members and key stakeholders recognize there is a need for a sustained and unbiased biosimilars education and advocacy program in the U.S.

To this end, the development of an independent non-profit forum to raise awareness of biosimilars and serve as a credible resource for information is timely. The Biosimilars Forum will provide an opportunity for companies developing biosimilars for the U.S. to work together and with other key stakeholders on topics instrumental to biosimilars and patient care.

Learn more about biosimilars, the Forum, and how to get involved, visit BiosimilarsForum.org, or go to @USBiosimilars to follow related conversations and join the dialogue.

Hydrogen’s advanced virtual primary care is designed to help your team thrive, delivering better outcomes and lower costs for everyone. As leaders and experts in healthcare implementation, member engagement, and integrated, value-based care, Hydrogen helps enterprises and health plans bring K Health’s advanced virtual primary care solution to their populations. More than a provider or an administrator, Hydrogen is your partner in building more equitable healthcare and a better future for all.

National Pharmaceutical CouncilThe National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation's major research-based pharmaceutical companies, NPC focuses on research development, information dissemination and education on the critical issues of evidence, innovation and the value of medicines for patients. For more information, visit www.npcnow.org and follow NPC on Twitter @npcnow.

Pear Therapeutics is the pioneer in Prescription Digital Therapeutics (PDTs), a new therapeutic class that uses software to treat disease.Our groundbreaking PDTs, reSET®, reSET-O® and Somryst® deliver new pathways to treat substance use disorder (SUD), opioid use disorder (OUD), and Chronic Insomnia, respectively.

Novo Nordisk, a global health care company, has been committed to discovering and developing innovative medicines to help people with serious chronic conditions lead longer, healthier lives with fewer limitations. We’re working toward a future where fewer people get chronic diseases, everyone is diagnosed, and all patients receive adequate treatment

Onduo is dedicated to making healthy easier, more accessible, and more personalized with our science-backed, data-driven virtual care model—one that can serve people living with chronic conditions and the organizations supporting them. Onduo provides digital, connected care with a human touch for diabetes, hypertension, weight loss, diabetes prevention, and mental and behavioral health. Enabled by technology built by Verily Life Sciences, we deliver lifestyle and clinical interventions that leverage deep analytics, connected smart devices, innovative software, and access to specialty care. To learn more, visit www.onduo.com.

Breakthroughs That Change Patients’ Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.

apree health is on a mission to build the first end-to-end healthcare solution that redefines the care experience and transforms the way patients access and engage with care, the way providers deliver care, and the way employers and other purchasers pay for care. apree health does this by combining best-in-class navigation and data-driven insights, the most advanced primary care model, and value-based risk models to unlock health outcomes and make life better for those it serves.

Centivo is a new type of digital health plan anchored around leading providers of value-based care. Centivo saves self-funded employers 15 percent or more compared to traditional insurance carriers and is easy to use for employers and employees. Our mission is to bring lower cost, higher quality healthcare to the millions of working Americans who struggle to pay their healthcare bills. With Centivo, employers can offer their employees affordable and predictable costs, a high-tech member experience, exceptional service, and a range of benefit options including both proprietary primary care-centered ACO models as well as traditional networks. For more information, visit centivo.com or follow us @Centivo on LinkedIn or @CentivoHealth on Twitter.

We’re a caring, innovative digital therapeutics company committed to reversing polychronic inflammatory illnesses through personalization. We empower individuals who struggle under the misguidance of one-size-fits-all care programs, the tyranny of multiple wellness apps that try to mask and manage symptoms of inflammatory illnesses linked to host genetics and gut microbiome - digestive disorders, anxiety, depression, sleep disorders, skin condition, and MSK chronic pain.

Ochsner Health has been providing high-quality clinical and hospital patient care to the people of Louisiana, Mississippi, and the Gulf South since 1942. Our healthcare family—today, comprising more than 30,000 employees and over 4,500 providers in over 90 medical specialties and subspecialties—is driven by our commitment to our mission to Serve, Heal, Lead, Educate and Innovate, and that passion is shared with every person who passes through our doors.
Ochsner's Digital Medicine solution provides one-on-one, personalized care to manage a member's high blood pressure or Type 2 diabetes without having to make multiple trips to the doctor. Real-time data is shared with the member's personal Digital Medicine care team, who monitors their readings and results to help make treatment decisions. The inclusion of a licensed clinician to manage medications allows for true management of the member’s condition rather than simply monitoring.

Driven by people and powered by technology, Primary.Health is a provider of health diagnostics solutions for large organizations committed to protecting their populations. Our mission is to end the spread of infectious diseases and reduce the severity of all illnesses by providing simple, affordable diagnostics and preventative care at scale. Primary.Health was born of a volunteer effort in a little California town to protect the health of one community, and we have grown into a company protecting over 6 million lives. We provide program management software and program design services that let employers, schools and communities administer testing to follow the recommendations of healthcare professionals. Through our work with the largest, most complex organizations at the height of the pandemic, Primary has earned the experience and trust to provide superior diagnostic testing for COVID-19, flu, STIs and other conditions that threaten population health.